- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Contemporary grading for prostate cancer: Implications for patient care - Abstract
November 20, 2012
A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment - Abstract
November 20, 2012
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer - Abstract
November 20, 2012
The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer - Abstract
November 20, 2012
Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management - Abstract
November 20, 2012
Anti-angiogenic therapies in prostate cancer - Abstract
November 20, 2012
Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese males - Abstract
November 20, 2012
The REDUCE metagram: A comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer - Abstract
November 19, 2012
Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer - Abstract
November 19, 2012
Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy - Abstract
November 19, 2012
Complications of laparoscopic radical prostatectomy-a single institute experience - Abstract
November 19, 2012
Strength training induces muscle hypertrophy and functional gains in Black prostate cancer patients despite androgen deprivation therapy - Abstract
November 19, 2012
Cabazitaxel: More than a new taxane for metastatic castrate-resistant prostate cancer? - Abstract
November 19, 2012
Management of docetaxel failures in metastatic castrate-resistant prostate cancer - Abstract
November 16, 2012